FOMX Foamix Pharmaceuticals Ltd.

2.54
-0.13  -5%
Previous Close 2.67
Open 2.67
Price To Book 1.78
Market Cap 138225080
Shares 54,419,323
Volume 187,689
Short Ratio
Av. Daily Volume 287,214

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

NDA filing due mid-2019.
FMX103
Papulopustular rosacea
PDUFA date October 20, 2019.
FMX101
Acne
Phase 2 data released December 2015
FDX104
Acne-like rash in cancer patients
Update to be provided as it materializes.
FDX102
Impetigo

Latest News

  1. Edited Transcript of FOMX earnings conference call or presentation 8-May-19 12:30pm GMT
  2. Foamix (FOMX): A Beaten-Down Biotech Stock That Looks Like a Bargain Now
  3. Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX): The Best Of Both Worlds
  4. Foamix Pharmaceuticals (FOMX) Q1 2019 Earnings Call Transcript
  5. Foamix (FOMX) Reports Q1 Loss, Misses Revenue Estimates
  6. Foamix: 1Q Earnings Snapshot
  7. Foamix Reports First Quarter 2019 Financial Results and Provides Corporate Update
  8. Foamix Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2019
  9. Will Foamix (FOMX) Report Negative Earnings Next Week? What You Should Know
  10. Foamix to Present Late Breaking Data at the 77th Annual Meeting of the Society for Investigative Dermatology
  11. Foamix Pharmaceuticals First Quarter 2019 Financial Results Conference Call & Webcast Scheduled for May 8
  12. This Small-Cap Biotech Stock Could Triple in 2019
  13. What Kind Of Share Price Volatility Should You Expect For Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)?
  14. Foamix Announces Settlement of Litigation with Perrigo Relating to Finacea Foam
  15. Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2019
  16. Edited Transcript of FOMX earnings conference call or presentation 1-Mar-19 1:30pm GMT
  17. Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
  18. Foamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference
  19. Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update
  20. How Many Insiders Bought Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Shares?